164 related articles for article (PubMed ID: 25128974)
1. Association of vascular endothelial factors with cardiovascular outcome and mortality in chronic kidney disease patients: a 4-year cohort study.
Rambod M; Heine GH; Seiler S; Dominic EA; Rogacev KS; Dwivedi R; Ramezani A; Wing MR; Amdur RL; Fliser D; Raj DS
Atherosclerosis; 2014 Oct; 236(2):360-5. PubMed ID: 25128974
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial.
Januzzi JL; Liu Y; Sattar N; Yavin Y; Pollock CA; Butler J; Jardine M; Heerspink HJL; Masson S; Breyer M; Hansen MK
Am Heart J; 2024 May; 271():38-47. PubMed ID: 38401646
[TBL] [Abstract][Full Text] [Related]
3. An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.
Matsumoto T; Uemura S; Takeda Y; Matsui M; Okada S; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Onoue K; Kawata H; Kawakami R; Horii M; Saito Y
Intern Med; 2013; 52(10):1019-27. PubMed ID: 23676585
[TBL] [Abstract][Full Text] [Related]
4. Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage.
Jayasena CN; Abbara A; Comninos AN; Narayanaswamy S; Gonzalez Maffe J; Izzi-Engbeaya C; Oldham J; Lee TT; Sarang Z; Malik Z; Dhanjal MK; Williamson C; Regan L; Bloom SR; Dhillo WS
Hum Reprod; 2016 Dec; 31(12):2681-2688. PubMed ID: 27664209
[TBL] [Abstract][Full Text] [Related]
5. Suppressed soluble Fms-like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney disease.
Matsui M; Takeda Y; Uemura S; Matsumoto T; Seno A; Onoue K; Tsushima H; Morimoto K; Soeda T; Okayama S; Somekawa S; Samejima K; Kawata H; Kawakami R; Nakatani K; Iwano M; Saito Y
Kidney Int; 2014 Feb; 85(2):393-403. PubMed ID: 24048373
[TBL] [Abstract][Full Text] [Related]
6. Association between angiogenic factors and signs of arterial aging in women with pre-eclampsia.
Akhter T; Wikström AK; Larsson M; Larsson A; Wikström G; Naessen T
Ultrasound Obstet Gynecol; 2017 Jul; 50(1):93-99. PubMed ID: 27256927
[TBL] [Abstract][Full Text] [Related]
7. [Influences on Placental Growth Factor (PlGF) and Soluble fms-like Tyrosine Kinase-1 (sFlt-1) Concentration Levels at the Time of First Trimester Screening].
von See J; Limperger V; Pecks U; Eckmann-Scholz C
Z Geburtshilfe Neonatol; 2016 Aug; 220(4):166-72. PubMed ID: 27135751
[TBL] [Abstract][Full Text] [Related]
8. Carotid intima-media thickness is an independent predictor of all-cause mortality and cardiovascular morbidity in patients with diabetes mellitus type 2 and chronic kidney disease.
Roumeliotis A; Roumeliotis S; Panagoutsos S; Theodoridis M; Argyriou C; Tavridou A; Georgiadis GS
Ren Fail; 2019 Nov; 41(1):131-138. PubMed ID: 30909780
[TBL] [Abstract][Full Text] [Related]
9. Placental Growth Factor as a Predictor of Cardiovascular Events in Patients with CKD from the NARA-CKD Study.
Matsui M; Uemura S; Takeda Y; Samejima K; Matsumoto T; Hasegawa A; Tsushima H; Hoshino E; Ueda T; Morimoto K; Okamoto K; Okada S; Onoue K; Okayama S; Kawata H; Kawakami R; Maruyama N; Akai Y; Iwano M; Shiiki H; Saito Y;
J Am Soc Nephrol; 2015 Nov; 26(11):2871-81. PubMed ID: 25788536
[TBL] [Abstract][Full Text] [Related]
10. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia.
Reddy M; Palmer K; Rolnik DL; Wallace EM; Mol BW; Da Silva Costa F
Ultrasound Obstet Gynecol; 2022 May; 59(5):596-605. PubMed ID: 34985800
[TBL] [Abstract][Full Text] [Related]
11. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study.
Mandai S; Kanda E; Iimori S; Naito S; Noda Y; Kikuchi H; Akazawa M; Oi K; Toda T; Sohara E; Okado T; Sasaki S; Rai T; Uchida S
Clin Exp Nephrol; 2017 Feb; 21(1):104-111. PubMed ID: 27039905
[TBL] [Abstract][Full Text] [Related]
12. The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure.
Ky B; French B; Ruparel K; Sweitzer NK; Fang JC; Levy WC; Sawyer DB; Cappola TP
J Am Coll Cardiol; 2011 Jul; 58(4):386-94. PubMed ID: 21757116
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of angiogenic factors in women with chronic kidney disease and suspected superimposed preeclampsia.
Molina-Pérez CJ; Nolasco-Leaños AG; Carrillo-Juárez RI; Leaños-Miranda A
J Nephrol; 2022 Jul; 35(6):1699-1708. PubMed ID: 35353367
[TBL] [Abstract][Full Text] [Related]
14. Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction.
Shinohara S; Uchida Y; Kasai M; Sunami R
Hypertens Pregnancy; 2017 Aug; 36(3):269-275. PubMed ID: 28737473
[TBL] [Abstract][Full Text] [Related]
15. The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia.
Aminuddin NA; Sutan R; Mahdy ZA; Rahman RA; Nasuruddin DN
PLoS One; 2022; 17(3):e0265080. PubMed ID: 35275947
[TBL] [Abstract][Full Text] [Related]
16. Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease.
Wiles K; Bramham K; Seed PT; Brockbank A; Nelson-Piercy C; Karumanchi SA; Lightstone L; Chappell LC
Pregnancy Hypertens; 2021 Jun; 24():58-64. PubMed ID: 33677420
[TBL] [Abstract][Full Text] [Related]
17. Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.
Park HJ; Kim SH; Jung YW; Shim SS; Kim JY; Cho YK; Farina A; Zanello M; Lee KJ; Cha DH
BMC Pregnancy Childbirth; 2014 Jan; 14():35. PubMed ID: 24444293
[TBL] [Abstract][Full Text] [Related]
18. Is It Possible to Differentiate Chronic Kidney Disease and Preeclampsia by means of New and Old Biomarkers? A Prospective Study.
Rolfo A; Attini R; Tavassoli E; Neve FV; Nigra M; Cicilano M; Nuzzo AM; Giuffrida D; Biolcati M; Nichelatti M; Gaglioti P; Todros T; Piccoli GB
Dis Markers; 2015; 2015():127083. PubMed ID: 26557728
[TBL] [Abstract][Full Text] [Related]
19. Association of ALOX12 gene polymorphism with all-cause and cardiovascular mortality in diabetic nephropathy.
Roumeliotis AK; Roumeliotis SK; Panagoutsos SA; Tsetsos F; Georgitsi M; Manolopoulos V; Paschou P; Passadakis PS
Int Urol Nephrol; 2018 Feb; 50(2):321-329. PubMed ID: 29196930
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic Factors and Risks of Technique Failure and Cardiovascular Events in Patients Receiving Peritoneal Dialysis.
Matsui M; Samejima K; Takeda Y; Morimoto K; Tagawa M; Onoue K; Okayama S; Kawata H; Kawakami R; Akai Y; Okura H; Saito Y
Cardiorenal Med; 2016 May; 6(3):251-9. PubMed ID: 27275161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
